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Abstract 
         Leaves from Blumea balsamifera (Lin.) DC. are used in traditional Thai and 
Chinese medicine for the treatment of septic wounds and other infections.  In the present 
study, essential oil, hexane, dichloromethane, and methanol extracts of these leaves were 
evaluated for antibacterial and antifungal activity using the disc diffusion assay and agar 
microdilution method.  The essential oil was the most potent, with an MIC of 150 µg/mL 
against Bacillus cereus and an MIC of 1.2 mg/mL against Staphylococcus aureus and 
Candida albicans.  Activity was also detected from the hexane extract against 
Enterobacter cloacae and S. aureus.  MBCs and MFCs were typically equal to or two-
fold higher than the MICs for both extracts, indicating microbicidal activity.  Data 
presented here shows that B. balsamifera extracts have activity against various infectious 
and toxin-producing microorganisms.  This plant’s active constituents could potentially 
be developed for use in the treatment and / or prevention of microbial disease. 
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1. Introduction 
 
         Antimicrobial resistance is a major global problem, with resistant strains of 
Staphylococcus aureus (Lee et al., 2009), Salmonella enterica serovar Typhi (WHO, 
2009), Candida albicans (Cannon et al., 2007) and other microorganisms being 
responsible for much morbidity and mortality.  Given that it takes between 12  and 15 
years to develop new drugs (Watkins, 2002), urgent research and development is 
required to replenish our existing suite of anti-infective medicines before they are 
completely ineffective.  In addition to the difficulties that antimicrobial resistance 
presents to the healthcare sector and pharmaceutical industry, recent reports of 
antibiotic resistance among foodborne bacteria such as Bacillus cereus (Park et al., 
2009) mean that the food and drink industry is increasingly involved in the search for 
interventions to reduce pathogens in foods and protect consumers. 
Humans have been using plants to treat infectious disease for thousands of 
years (Atta-ur-Rahman, 2008), and it was recently estimated by the World Health 
Organization (WHO) that 25% of modern medicines are derived from plants that were 
first used in traditional medicine (WHO, 2003).  Potential applications for 
phytochemicals include use as antibacterial agents (Kumarasamy et al., 2005; Süzgeç 
et al. 2005), antifungal agents (Boonphong et al., 2007), and antibiotic resistance 
modulating agents (Fujita et al., 2005).  In recent years, it has also been proposed that 
phytochemicals such as orange oil (Nannapaneni et al., 2009), oregano oil (Friedman 
et al., 2006) and green tea extracts (Friedman, 2007) could be used to enhance 
microbial food safety. 
Blumea balsamifera (Lin.) DC. (Compositae) is a halfwoody, evergreen shrub 
that grows widely throughout East and South East Asia.  This plant has numerous 
uses in traditional Thai and Chinese medicine including the treatment of septic 
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wounds (Ruangrungsi et al., 1985), respiratory infections and stomach pains (ICRAF, 
2009).  Preparation of the plant involves pounding the leaves for use in poultices, 
drying the leaves for smoking, or boiling the leaves so that the infusion may be used 
for bathing, inhalation or drinking (Ruangrungsi et al., 1985; ICRAF, 2009).  The aim 
of the current study was to assess the potential for B. balsamifera components to be 
used in modern medicine and / or food safety by determining the spectrum, potency 
and nature of activity of various extracts of the plant. 
 
2. Materials and methods 
2.1 Plant material 
 
         B. balsamifera (Lin.) DC. was collected from Roi-Et Province in northeast 
Thailand at the end of the cool season (02-02-04).  A voucher specimen (herbarium 
number WRBI 305) was deposited with the Walai Rukhavej Botanical Research 
Institute (Mahasarakham University, Thailand).  Plant material was air-dried in the 
shade at room temperature for 10 days. 
 
2.2 Extraction 
 
         Three aliquots of the dried leaves of B. balsamifera (3 x 300 g) were extracted 
with hexane, dichloromethane and methanol.  Each of the different extractions was 
performed at room temperature a total of three times (3 x 800 mL), 48 hours each 
time.  All extracts were evaporated in vacuo and stored in the dark at 4ºC until 
required.  A fourth aliquot of the air-dried leaves of B. balsamifera (300 g) was 
subjected to hydrodistillation for 3 hours using a Clevenger type apparatus.  The oil 
was dried over anhydrous sodium sulphate and stored in a sealed vial in the dark at 
4ºC until required. 
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2.3 Preparation of test solutions and discs 
 
         Test solutions were prepared containing 19.2 mg/mL extract in 5 % (v/v) 
aqueous dimethyl sulphoxide (DMSO).  Whatman no. 1 sterile filter paper discs (6 
mm) were impregnated with 20 µL of extract (corresponding to 384 µg extract) and 
allowed to dry at room temperature. 
 
2.4 Microorganisms 
 
         Standard reference strains of bacteria used in the study were B. cereus ATCC 
11778, S. aureus ATCC 25923, Enterobacter cloacae DMST 17206, E. coli ATCC 
25922, Pseudomonas aeruginosa ATCC 27853, and S. Typhi DMST 5784.  The 
fungal strain C. albicans ATCC 10231 was also used.  These were all obtained from 
the Department of Medical Sciences, Ministry of Public Health, Thailand.  In 
addition, clinical isolates of B. cereus, S. aureus, E. cloacae, E. coli, Klebsiella 
pneumoniae, P. aeruginosa, and S. Typhi (strains MSH 001 to 007) were obtained 
from Mahasarakham Hospital, Mahasarakham Province, Thailand.   
Prior to experiments, bacteria were cultured on nutrient agar for 24 hours at 
37ºC, while C. albicans was cultured on potato dextrose agar for 48 hours at 25ºC.  
Inocula were prepared by suspending colonies of the above microorganisms in 0.9 % 
(w/v) sodium chloride solution, and adjusting these to achieve turbidity equivalent to 
a 0.5 McFarland standard.   
 
2.5 Screening for antibacterial and antifungal activity 
 
         Antimicrobial screening was performed using the disc diffusion method.  This 
involved preparing agar plates containing 10 mL nutrient agar (for antibacterial 
testing) or potato dextrose agar (for antifungal testing), inoculating the surface of 
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these with 0.1 mL of ~1 x 10
6
 cfu/mL bacteria or C. albicans, allowing this to dry, 
and applying discs of the plant extracts.  Discs containing penicillin, chloramphenicol, 
tetracycline and gentamycin were also tested for comparison.  Agar plates of bacteria 
were then incubated at 37ºC for 24 hours, while agar plates of C. albicans were 
incubated at 25ºC for 48 hours.  Inhibition zones were measured from the edge of the 
disc to the inner margin of the surrounding pathogens.  Experiments were repeated to 
verify the reproducibility of results. 
 
2.6 Determination of minimum inhibitory concentrations (MICs) 
 
         MICs were determined for the plant extracts using the method of 
Chandrasekaran and Venkatesalu (2004).  This entailed preparing a dilution series of 
the different plant extracts in nutrient or potato dextrose agar and inoculating these 
with 50 µL of ~1 x 10
6
 cfu/mL bacteria or fungi.  Control tubes containing solvent but 
no plant extract were also tested.  The final volume in each tube was 1 mL and the 
highest concentration of each plant extract tested was 9.6 mg/mL.  Tubes inoculated 
with bacteria were incubated at 37ºC for 24 hours, while those inoculated with C. 
albicans were incubated at 25ºC for 48 hours.  MICs were determined by identifying 
the lowest concentration of plant extract which completely inhibited microbial 
growth. 
 
2.7 Determination of minimum bactericidal and minimum fungicidal 
concentrations (MBCs and MFCs) 
 
         MBC and MFC values were also determined according to the method described 
previously (Chandrasekaran and Venkatesalu, 2004).  In brief, this involved 
identifying tubes from the MIC assay which did not show any growth, resuspending 
the microorganisms in nutrient or potato dextrose broth, and subculturing this onto the 
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surface of nutrient or potato dextrose agar.  As before, plates inoculated with bacteria 
were incubated at 37ºC for 24 hours, while those inoculated with C. albicans were 
incubated at 25ºC for 48 hours.  MBC and MFC values were determined by 
identifying the lowest concentration of extract that did not permit any visible growth. 
 
3. Results and discussion 
 
         When different extracts of B. balsamifera were screened for activity using the 
disc diffusion method, it was the essential oil which was identified as having the most 
potent antimicrobial activity (Table 1).  The essential oil was responsible for 19 mm 
and 12 mm zones of inhibition in agar plates inoculated with clinical isolates of the 
Gram positive bacteria S. aureus and B. cereus.  This extract was also found to have 
activity against the pathogenic fungus C. albicans.  Of the four plant extracts 
examined, it was the hexane extract which appeared to have the broadest spectrum of 
activity though (Table 1), inhibiting two strains of S. aureus and two strains of the 
Gram negative bacterium E. cloacae.  Although this does not compare favourably 
with the spectrum of activity of the antibiotics tested (Table 1), it is worth noting that 
the bacteria against which the hexane extract is effective are very problematic species.  
Infections caused by S. aureus, in particular, are being seen with increasing 
prevalence in both the hospital (Rubinstein, 2008) and community (Moellering, 2006), 
and there is evidence to suggest that this species is becoming increasingly pathogenic 
(Otto, 2009) and decreasingly susceptible to the drug of last resort vancomycin 
(Gould, 2008).  With regard to the dichloromethane extract, this was found to have a 
similar level of inhibitory activity against E. cloacae as the hexane extract, but no 
activity was detected against S. aureus.  No activity whatsoever was detected from the 
methanol extract and work with this extract was discontinued.   
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Data from subsequent assays where the inhibitory and microbicidal activity of 
the extracts was measured (Table 2) correlates well with results from the screening 
work (Table 1).  As before, the essential oil was found to be the most potent of the 
extracts, with an MIC of just 150 µg/mL against B. cereus and an MIC of 1.2 mg/mL 
against S. aureus and C. albicans.  In addition to having inhibitory activity against 
Gram positive bacteria and the fungal pathogen C. albicans, results from the MBC 
and MFC assays suggest that B. balsamifera essential oil has microbicidal activity.  
Characterisation of plant extracts as microbiostatic or microbicidal has become a 
complicated matter in recent years (Cushnie et al., 2007).  However, the method used 
to determine MBC and MFC values in the current study involved transferring all (as 
opposed to just a sample) of the original inoculum onto agar.  This means that the 
observed results can be attributed to bacterial cell death, rather than cell aggregation.  
Antimicrobial agents with MBC and MFC values no higher than two to four times the 
MIC are considered microbicidal (Prescott et al., 1999) and this was the case for the 
essential oil. 
As observed in the screening data, the hexane extract was found to have 
inhibitory activity against both Gram positive S. aureus and Gram negative E. 
cloacae, with MICs of 9.6 mg/mL and 4.8 mg/mL respectively (Table 2).  Though 
these values are quite high, it should be borne in mind that the active constituent(s) of 
the extract may be present in small quantities.  MBC data indicates that the hexane 
extract has bactericidal activity against E. cloacae.  This finding is encouraging as 
Gram negative bacteria have notoriously low susceptibility to antibacterial agents due 
to the low permeability of their cell envelope (Delcour, 2009).  Indeed, there is 
considerable concern among experts about the lack of drugs that are effective against 
Gram negative bacteria (Vergidis and Falagas, 2008).  The dichloromethane extract of 
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B. balsamifera, in comparison to the hexane extract, was found to have quite weak 
inhibitory activity and no detectable bactericidal activity.  
When data from Tables 1 and 2 are viewed together, it is clear that the hexane 
extract and essential oil of B. balsamifera are effective against different classes of 
microorganism.  This indicates that different constituents are likely to be responsible 
for the activity of these two extracts.  At the present time the identity of these 
constituents remains to be elucidated, but there has been a previous report of an 
antifungal compound, icthyothereol acetate, being isolated from B. balsamifera 
(Ragasa et al., 2005).  Several flavonoids (Ali et al., 2005; Hasegawa et al., 2006) and 
sesquiterpenoids (Osaki et al., 2005) have also been isolated from B. balsamifera.  
Though none of these compounds have been tested for antibacterial or antifungal 
activity, certain flavonoids and sesquiterpenoids are known to be antimicrobial (Rabe 
and van Staden, 2000; Cushnie and Lamb, 2005), and it is conceivable that these 
constituents are contributing to the activity of this plant. 
In summary, data presented here shows that B. balsamifera has antimicrobial 
activity, a finding which may explain the herb’s use in traditional medicine.  Of the 
various extracts of the plant examined, it was the essential oil and hexane extract 
which had the greatest activity in terms of potency and spectrum.  Through future 
research, it may be possible to isolate and develop the compounds responsible for this 
activity.  Data from the current study suggests that these agents could be useful 
against S. aureus, E. cloacae and C. albicans infections, especially if administered 
topically, where clinically effective doses would be more readily achievable.  In 
addition, the compounds could potentially be developed as food additives for the 
prevention of foodborne diseases caused by S. aureus and B. cereus. 
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Table 1 Antimicrobial activity of Blumea balsamifera extracts and essential oil as determined by the disc diffusion assay. 
 
Microorganism  Zones of inhibition (mm) for different extracts and antibacterial agents 
Hexane 
384 µg / disc 
Dichloromethane 
384 µg / disc 
Essential oil 
384 µg / disc 
Penicillin 
10 U / disc 
Chloramphenicol 
30 µg / disc 
Tetracycline 
30 µg / disc 
Gentamycin 
10 µg / disc 
Gram positive bacteria 
B. cereus ATCC 11778 
B. cereus MSH 001 
S. aureus ATCC 25923 
S. aureus MSH 002 
 
- 
- 
8 
6.5 
 
- 
- 
- 
- 
 
- 
12 
- 
19 
 
12 
12 
12 
11 
 
23 
24 
21 
22 
 
29 
32 
22 
28 
 
22 
22 
20 
21 
Gram negative bacteria 
E. cloacae DMST 17206 
E. cloacae MSH 003 
E. coli ATCC 25922 
E. coli MSH 004 
K. pneumoniae MSH 005 
P. aeruginosa ATCC 27853 
P. aeruginosa MSH 006 
S. Typhi DMST 5784 
S. Typhi MSH 007 
 
7 
6.5 
- 
- 
- 
- 
- 
- 
- 
 
8 
7 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 
14 
12 
13 
12 
13 
- 
- 
19 
- 
 
7 
11 
26 
24 
22 
23 
26 
26 
27 
 
7 
7 
23 
21 
21 
24 
15 
20 
26 
 
10 
7 
15 
18 
14 
24 
20 
14 
18 
Fungi 
C. albicans ATCC 10231 
 
- 
 
- 
 
9 
 
- 
 
9 
 
8 
 
8 
Note: Zones of inhibition were measured after 24 hours incubation for bacteria and 48 hours for C. albicans; No inhibitory activity was detected from the methanol extract  
against any of the microbial spp.;  -, no zone of inhibition 
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Table 2 Antimicrobial activity of Blumea balsamifera extracts and essential oil as 
determined by MIC, MBC and MFC assays. 
 
Microorganism Hexane Dichloromethane Essential oil 
MIC 
(mg/mL) 
MBC/MFC 
(mg/mL) 
MIC 
(mg/mL) 
MBC/MFC 
(mg/mL) 
MIC 
(mg/mL) 
MBC/MFC 
(mg/mL) 
Gram positive bacteria 
B. cereus ATCC 11778 
S. aureus ATCC 25923 
 
- 
9.6 
 
NT 
- 
 
- 
- 
 
NT 
NT 
 
0.15 
1.2 
 
0.15 
1.2 
Gram negative bacteria 
E. cloacae DMST 17206 
 
4.8 
 
9.6 
 
9.6 
 
- 
 
- 
 
NT 
Fungi 
C. albicans ATCC 10231 
 
- 
 
NT 
 
- 
 
NT 
 
1.2 
 
1.2 
Note: Results were recorded after 24 hours incubation for bacteria and 48 hours for C. albicans;  MIC, minimum 
inhibitory concentration;  MBC, minimum bactericidal concentration;  MFC, minimum fungicidal concentration;   
-, no activity detected;  NT, not tested due to insufficient level of activity in MIC assay 
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